HMGBiotech will join IMIG2023 through a workshop speech by Dr. Andrea Lamarca. IMIG2023 (26th-28th June, Lille) is an established international conference, now in its 16th edition, promoted by the International Mesothelioma Interest Group (iMig) and French Cooperative Thoracic Intergroup (IFCT).
This important event will boost networking opportunities with leading scientists, researchers, patients, and their associations. The aim of IMIG2023 is to stimulating ideas that will help to establish research collaborations and to fund projects regarding mesothelioma topics.
Dr. Lamarca during his speech will focus on the use of BoxA from HMGB1 protein in researches involving mesothelioma, highlighting how this highly conserved DNA binding domains of HMGB1 has a great biological impact and its possible outcomes.
Discover more about BoxA from HMGB1 protein.
